Sarah Kiely | Investor Relations and Corporate Communications |
Mark Enyedy | President and CEO |
Anna Berkenblit | Chief Medical Officer |
Dave Johnston | Chief Financial Officer |
Rich Gregory | Chief Scientific Officer |
Yige Guo | Guggenheim Partners |
Jonathan Chang | Leerink Partners |
Debjit Chattopadhyay | H.C. Wainwright |
John Newman | Canaccord |
Andy Hsieh | William Blair |
Kennen MacKay | RBC Capital Markets |
Jessica Fye | JPMorgan |
Boris Peaker | Cowen |
Joseph Catanzaro | Piper Jaffray |
Good day, and welcome, everyone, to this ImmunoGen Third Quarter 2018 Financial Results Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Sarah Kiely, Investor Relations and Corporate Communications. Please go ahead.
Good morning, and thank you for joining today's call.